Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: Systematic review and meta-analysis Review uri icon

Overview

MeSH Major

  • Acute Coronary Syndrome
  • Angioplasty, Balloon, Coronary
  • Anticoagulants
  • Enoxaparin
  • Heparin
  • Myocardial Infarction

abstract

  • Enoxaparin seems to be superior to unfractionated heparin in reducing mortality and bleeding outcomes during percutaneous coronary intervention and particularly in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.

publication date

  • February 18, 2012

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC3271999

Digital Object Identifier (DOI)

  • 10.1136/bmj.e553

PubMed ID

  • 22306479

Additional Document Info

start page

  • e553

volume

  • 344

number

  • 7844